Multisite comparison of anti-human immunodeficiency virus microbicide activity in explant assays using a novel endpoint analysis

Journal of Clinical Microbiology

Volumn 47, Issue 11, 2009, Pages 3530-3539

  Richardson Harman, Nicola ^a,i   Lackman Smith, Carol ^a   Fletcher, Patricia S ^b   Anton, Peter A ^c   Bremer, James W ^d   Dezzutti, Charlene S ^e   Elliott, Julie ^c   Grivel, Jean Charles ^f   Guenthner, Patricia ^g   Gupta, Phalguni ^h   Jones, Maureen ^a   Lurain, Nell S ^d   Margolis, Leonid B ^f   Mohan, Swarna ^e   Ratner, Deena ^h   Reichelderfer, Patricia ^f   Roberts, Paula ^a   Shattock, Robin J ^b   Cummins Jr , James E ^a  

^a SOUTHERN RESEARCH INSTITUTE   (United States)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^h UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

ⁱ ALPHA STATCONSULT LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROBICIDE; PRO 2000;

ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; VIROGENESIS; VIRUS INHIBITION;

ANTI-INFECTIVE AGENTS; CERVIX UTERI; FEMALE; HIV-1; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MUCOUS MEMBRANE; PALATINE TONSIL; RECTUM; REPRODUCIBILITY OF RESULTS; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 70449686243     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00673-09     Document Type: Article

References (34)

1. Abner, S. R., P. C. Guenthner, J. Guarner, K. A. Hancock, J. E. Cummins, Jr., A. Fink, G. T. Gilmore, C. Staley, A. Ward, O. Ali, S. Binderow, S. Cohen, L. A. Grohskopf, L. Paxton, C. E. Hart, and C. S. Dezzutti. 2005. A human colorectal explant culture to evaluate topical microbicides for the prevention of HIV infection. J. Infect. Dis. 192:1545-1556.
2. Collins, K. B., B. K. Patterson, G. J. Naus, D. V. Landers, and P. Gupta. 2000. Development of an in vitro organ culture model to study transmission of HIV-1 in the female genital tract. Nat. Med. 6:475-479.
3. Collman, R., N. F. Hassan, R. Walker, B. Godfrey, J. Cutilli, J. C. Hastings, H. Friedman, S. D. Douglas, and N. Nathanson. 1989. Infection of monocyte-derived macrophages with human immunodeficiency virus type 1 (HIV-1). Monocyte-tropic and lymphocyte-tropic strains of HIV-1 show distinctive patterns of replication in a panel of cell types. J. Exp. Med. 170:1149-1163.
4. Cummins, J. E., Jr., J. Guarner, L. Flowers, P. C. Guenthner, J. Bartlett, T. Morken, L. A. Grohskopf, L. Paxton, and C. S. Dezzutti. 2007. Preclinical testing of candidate topical microbicides for anti-human immunodeficiency virus type 1 activity and tissue toxicity in a human cervical explant culture. Antimicrob. Agents Chemother. 51:1770-1779.
5. Dezzutti, C. S., V. N. James, A. Ramos, S. T. Sullivan, A. Siddig, T. J. Bush, L. A. Grohskopf, L. Paxton, S. Subbarao, and C. E. Hart. 2004. In vitro comparison of topical microbicides for prevention of human immunodeficiency virus type 1 transmission. Antimicrob. Agents Chemother. 48:3834-3844.
6. Fischetti, L., S. M. Barry, T. J. Hope, and R. J. Shattock. 2009. HIV-1 infection of human penile explant tissue and protection by candidate microbicides. AIDS 28:319-328.
7. Fletcher, P., Y. Kiselyeva, G. Wallace, J. Romano, G. Griffin, L. Margolis, and R. Shattock. 2005. The nonnucleoside reverse transcriptase inhibitor UC-781 inhibits human immunodeficiency virus type 1 infection of human cervical tissue and dissemination by migratory cells. J. Virol. 79:11179-11186. (Pubitemid 41170659)
8. Fletcher, P. S., J. Elliott, J. C. Grivel, L. Margolis, P. Anton, I. McGowan, and R. J. Shattock. 2006. Ex vivo culture of human colorectal tissue for the evaluation of candidate microbicides. AIDS 20:1237-1245. (Pubitemid 44030371)
9. Fletcher, P. S., G. S. Wallace, P. M. Mesquita, and R. J. Shattock. 2006. Candidate polyanion microbicides inhibit HIV-1 infection and dissemination pathways in human cervical explants. Retrovirology 3:46.
10. Flint, S. J., L. W. Enquist, V. R. Racaniello, and A. M. Skalka (ed.). 2004. Principles of virology: molecular biology, pathogenesis, and control of animal viruses, 2nd ed. ASM Press, Washington, DC.
11. Fox-Canale, A. M., T. J. Hope, J. Martinson, J. R. Lurain, A. W. Rademaker, J. W. Bremer, A. Landay, G. T. Spear, and N. S. Lurain. 2007. Human cytomegalovirus and human immunodeficiency virus type-1 co-infection in human cervical tissue. Virology 369:55-68. (Pubitemid 350047473)
12. Glushakova, S., B. Baibakov, L. B. Margolis, and J. Zimmerberg. 1995. Infection of human tonsil histocultures: a model for HIV pathogenesis. Nat. Med. 1:1320-1322.
13. Greenhead, P., P. Hayes, P. S. Watts, K. G. Laing, G. E. Griffin, and R. J. Shattock. 2000. Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides. J. Virol. 74:5577-5586. (Pubitemid 30346592)
14. Grivel, J. C., J. Elliott, A. Lisco, A. Biancotto, C. Condack, R. J. Shattock, I. McGowan, L. Margolis, and P. Anton. 2007. HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1. AIDS 21:1263-1272.
15. Grivel, J. C., and L. B. Margolis. 1999. CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue. Nat. Med. 5:344-346.
16. Gupta, P., K. B. Collins, D. Ratner, S. Watkins, G. J. Naus, D. V. Landers, and B. K. Patterson. 2002. Memory CD4(+) T cells are the earliest detectable human immunodeficiency virus type 1 (HIV-1)-infected cells in the female genital mucosal tissue during HIV-1 transmission in an organ culture system. J. Virol. 76:9868-9876. (Pubitemid 35006526)
17. Gupta, P., D. Ratner, B. K. Patterson, K. Kulka, L. C. Rohan, M. A. Parniak, C. E. Isaacs, and S. Hillier. 2006. Use of frozen-thawed cervical tissues in the organ culture system to measure anti-HIV activities of candidate microbicides. AIDS Res. Hum. Retrovir. 22:419-424.
18. Khattree, R. 2000. Multivariate data reduction and discrimination with SAS® software. SAS Institute Inc., Cary, NC.
19. Klasse, P. J., R. J. Shattock, and J. P. Moore. 2006. Which topical microbicides for blocking HIV-1 transmission will work in the real world? PLoS Med. 3:e351.
20. Lackman-Smith, C., C. Osterling, K. Luckenbaugh, M. Mankowski, B. Snyder, G. Lewis, J. Paull, A. Profy, R. G. Ptak, R. W. Buckheit, Jr., K. M. Watson, J. E. Cummins, Jr., and B. E. Sanders-Beer. 2008. Development of a comprehensive human immunodeficiency virus type 1 screening algorithm for discovery and preclinical testing of topical microbicides. Antimicrob. Agents Chemother. 52:1768-1781.
21. Munoz-Fernandez, M. A., J. Navarro, M. G. Montes, J. Cosin, J. M. Zabay, and E. Fernandez-Cruz. 1996. Quantification of low levels of human immunodeficiency virus (HIV) type 1 RNA in P24 antigen-negative, asymptomatic, HIV-positive patients by PCR. J. Clin. Microbiol. 34:404-408.
22. Niioka, T., T. Uno, N. Yasui-Furukori, M. Shimizu, K. Sugawara, and T. Tateishi. 2006. Identification of the time-point which gives a plasma rabeprazole concentration that adequately reflects the area under the concentration-time curve. Eur. J. Clin. Pharmacol. 62:855-861.
23. Patterson, B. K., A. Landay, J. N. Siegel, Z. Flener, D. Pessis, A. Chaviano, and R. C. Bailey. 2002. Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture. Am. J. Pathol. 161:867-873.
24. Reed, G. F., F. Lynn, and B. D. Meade. 2002. Use of coefficient of variation in assessing variability of quantitative assays. Clin. Diagn. Lab. Immunol. 9:1235-1239.
25. Richardson, B. A., and J. Overbaugh. 2005. Basic statistical considerations in virological experiments. J. Virol. 79:669-676.
26. Roth, S., M. Monsour, A. Dowland, P. C. Guenthner, K. Hancock, C. Y. Ou, and C. S. Dezzutti. 2007. Effect of topical microbicides on infectious human immunodeficiency virus type 1 binding to epithelial cells. Antimicrob. Agents Chemother. 51:1972-1978.
27. Rusconi, S., M. Moonis, D. P. Merrill, P. V. Pallai, E. A. Neidhardt, S. K. Singh, K. J. Willis, M. S. Osburne, A. T. Profy, J. C. Jenson, and M. S. Hirsch. 1996. Naphthalene sulfonate polymers with CD4-blocking and anti-human immunodeficiency virus type 1 activities. Antimicrob. Agents Chemother. 40:234-236.
28. SAS Institute, Inc. 1990. SAS/STAT users guide, version 6, 4th ed. SAS Institute Inc., Cary, NC.
29. Scordi-Bello, I. A., A. Mosoian, C. He, Y. Chen, Y. Cheng, G. A. Jarvis, M. J. Keller, K. Hogarty, D. P. Waller, A. T. Profy, B. C. Herold, and M. E. Klotman. 2005. Candidate sulfonated and sulfated topical microbicides: comparison of anti-human immunodeficiency virus activities and mechanisms of action. Antimicrob. Agents Chemother. 49:3607-3615.
30. Sutthent, R., N. Gaudart, K. Chokpaibulkit, N. Tanliang, C. Kanoksinsombath, and P. Chaisilwatana. 2003. p24 antigen detection assay modified with a booster step for diagnosis and monitoring of human immunodeficiency virus type 1 infection. J. Clin. Microbiol. 41:1016-1022.
31. Taylor, R. N., K. M. Fulford, and A. Y. Huong. 1978. Comparison of kinetic and end-point diffusion methods for quantitating human serum immunoglobulins. J. Clin. Microbiol. 8:23-27.
32. Tsai, W. P., S. R. Conley, H. F. Kung, R. R. Garrity, and P. L. Nara. 1996. Preliminary in vitro growth cycle and transmission studies of HIV-1 in an autologous primary cell assay of blood-derived macrophages and peripheral blood mononuclear cells. Virology 226:205-216.
33. Wang, G. P., and F. D. Bushman. 2006. A statistical method for comparing viral growth curves. J. Virol. Methods 135:118-123.
34. Yeh, S. H. 1991. Using the trapezoidal rule for the area under the curve calculation. SAS Users Group Int. 27:227-229.